Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...

The study will focus on combination use of the Allurion Balloon with lower dose GLP-1s with the goal of demonstrating improved long-term tolerability and adherence to GLP-1 therapy. Previous ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

announced today its plan to conduct a clinical study on the combined use of the Allurion Balloon and GLP-1 agonists, aiming to improve long-term adherence and tolerability to GLP-1 therapy.

Although the Allurion Balloon is currently an investigational device in the United States, the company offers the Allurion Virtual Care Suite to healthcare providers separately to tailor weight-loss ...

Winthrop Hot Air Balloon Roundup is a highly-anticipated event in Washington. Mark your calendar this February so you don't ...

“The goal of our study would be to prove that, by combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy, patients can lose significant weight while increasing muscle ...

In addition, the Company closed its previously announced concurrent private placement with funds affiliated with Leavitt Equity Partners for the purchase and sale of 267,686 shares of common stock and ...

The Remount Foundation offers free mental health services, using horses to help military members combat PTSD, depression, and ...

RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...

Dr. Gaur added that if the balloon-GLP-1 combination is successful ... "Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program." ...